Company: MDCXW
Filing Date: 2025-09-19
Form Type: DRS
Source: 0001062993-25-015719
Chunk: 266

Company: Medicus Pharma Ltd.
Filing Date: 2025-09-19
Form: DRS
Chunk 266
---
 2030 Warrants were estimated using the Black-Scholes model with the following assumptions:

|                            |   |     Issue Date 
 March 10, 2025 |     |   |   Issue Date 
 June 2, 2025 |
|:---------------------------|:--|---------------:|:----|:--|-------------:|
| Valuation date share price | $ |           3.40 |     | $ |         2.63 |
| Exercise price             | $ |           2.80 |     | $ |         3.10 |
| Dividend yield             |   |              - |     |   |            - |
| Risk-free interest rate    |   |          3.98% |     |   |        4.01% |
| Expected warrant life      |   |     5.00 years |     |   |   5.00 years |
| Expected volatility        |   |         97.81% |     |   |       97.42% |

As of June 30, 2025, 133,800 of the 1,490,000 Regulation A Warrants have been exercised for cash, with 5,000 being exercised in the three months ended March 31, 2025, for proceeds to the Company of $374,640 ($14,000 of which related to the three months ended March 31, 2025).

Initial Public Offering

On November 14, 2024, the Company completed its initial public offering ("IPO") with the sale of 970,000 Units at the price of $4.125 per Unit, with each Unit (the "Unit") consisting of one common share and one warrant (the "Public Warrants" and with the Regulation A Warrants and the June 2030 Warrants, the "Warrants") to purchase one common share at the exercise price of $4.64 per share. The Public Warrants expire five years from their date of issuance on November 15, 2029. In addition, the underwriters exercised an option to purchase 145,500 Public Warrants (the "Overallotment Warrants") at a price of $0.01 per warrant.

Total gross proceeds from the IPO were $4,002,705, including the proceeds from the Overallotment Warrants. The Company incurred total issuance costs of $2,218,014, including underwriter fees, and legal and other professional fees